Circulating tumor DNA predicts prognosis of mCRC patients receiving first-line bevacizumab based-chemotherapy
CITATION STYLE
Urbini, M., Marisi, G., Azzali, I., Bartolini, G., Chiadini, E., Capelli, L., … Passardi, A. (2023). Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. JCO Precision Oncology, (7). https://doi.org/10.1200/po.22.00694
Mendeley helps you to discover research relevant for your work.